USPTO 2015–2025 USPTO PatentsView US Corporation

Camfil USA, Inc.

USPTO PatentsView assignee record - 24 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01D (Separation).

RSS updates for this company

The verdict

According to USPTO PatentsView, Camfil ranks #12,380 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 12 technology areas.

#12,380
of 49,997 US assignees by volume
37th percentile
by Innovation Score (31.2/100)
13.1
avg claims per patent
-90%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12380 · US Corporation #12,380 · 24 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 24 grants
  • UPPER-Q #12,380/49,997
  • PHOTO-FINISH Biotest
  • CPC-FOCUS B01D · 12 areas
  • INNOV-THIN 31.2/100
  • CLAIMS-RICH 13.1 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -90% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Biotest AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Camfil’s 31.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Camfil

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Camfil's Innovation Score is 31.2/100 (37th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Camfil?

Each dot is one of Camfil’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Camfil’s own 13.1 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Camfil vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 23.923.92424.1 0510152025 Granted patents (volume) Avg claims / patent Biotest AG - 24, 22.04BiotestBison Designs, LLC - 24, 1Bison DesignsBurton Technologies, LLC - 24, 12.17BurtonCalitor Sciences, LLC - 24, 17.42Calitor SciencesCentrillion Technology Holdings Corporation - 24, 17.92Centrillion Techn…China National Offshore OIL Corporation - 24, 12.46China National Of…Claas Saulgau GmbH - 24, 11.29Claas SaulgauConstellium Neuf-brisach - 24, 16.75Constellium Neuf-…Camfil USA, Inc. - 24, 13.08Camfil USA
Camfil vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Camfil's grants concentrate

Camfil USA, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 79.2% of grants classified under B01D (Separation). Peak complete grant year is 2015 (10 grants) versus a trough of 1 in 2017. By volume, Camfil sits between Biotest AG and Constellium Neuf-brisach.

Who files at Camfil's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Camfil holds 24 patents at rank #12,380, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Camfil

By rank, the assignees closest to #12,380 in granted patent volume.

Leaders in B01D (Separation)

Other assignees with the most granted patents in Camfil's primary technology class.

Camfil's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 37th percentile higher than 37% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 2015201620172018201920202025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Camfil USA, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 10 41.7%
2016 4 16.7%
2017 1 4.2%
2018 3 12.5%
2019 3 12.5%
2020 2 8.3%
2025partial year 1 4.2%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Camfil USA, Inc.'s patent record in context - here's where to go next.

  • Camfil USA, Inc.'s lead technology class is B01D (Separation), 79.2% of its portfolio - see every assignee active in that class. Explore B01D
  • Ranked #12,380 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Camfil USA, Inc. against Biotest AG, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 31.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.